HODGKİN OLMAYAN LENFOMA KEMOTERAPİ PROTOKOLLERİ

Kaynaklar:

1-Chaganti S et al. BSH Guidelines for the management of diffuse large B- cell Lymphoma. BJH 2016; 174(1):43-56 

2- Feugier P et al. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol. 2005; 23(18):4117-26. 

3- Pfreundschuh M et al. German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL). Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ Bcell lymphomas: a randomised controlled trial (RICOVER-60). Lancet Oncol. 2008; 9(2):105-16. 

4- Pfreundschuh M et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol 2006; 7:379-91. 

5- Peter Sidaway. R-CHOP can be safely de-escalated in NHL. Nature Reviews Clinical Oncology volume 17, page135 (2020).